ConductScience.org, home

Paper5115151

Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.

Lowbury EJ and 3 others. Injury, 1971. Cited by 22 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Papers, record 5115151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5115151

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim.
PubMed
Journal
Injury
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.04
iCite
Revised in PubMed
2019-08-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lowbury EJE J
2Jackson DMD M
3Ricketts CRC R
4Davis BB

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
BurnsMajor topic
Folic Acid AntagonistsMajor topic
PyrimidinesMajor topic
Silver NitrateMajor topic
SulfadiazineMajor topic
Wound InfectionMajor topic
Adolescent
Adult
Aged
Child
Child, Preschool
Drug Resistance, Microbial
Humans
Infant
Microbial Sensitivity Tests
Middle Aged
Proteus Infections
Pseudomonas Infections
Staphylococcal Infections
Trimethoprim

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
27980916Self-Assembled Soft Nanomaterials Via Silver(I)-Coordination: Nanotube, Nanofiber, and Remarkably Enhanced Antibacterial Effect.Adv Sci (Weinh)2015https://conductscience.org/library/papers/27980916PubMed
22693632Nanohybrids of silver particles immobilized on silicate platelet for infected wound healing.PLoS One2012https://conductscience.org/library/papers/22693632PubMed
15825409Mechanism of silver sulfadiazine action on burn wound infections.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15825409PubMed
5000382Control of infection with gram-negative bacteria in patients at special risk.Proc R Soc Med1971https://conductscience.org/library/papers/5000382PubMed
4840432Properties of silver sulfadiazine-resistant Enterobacter cloacae.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840432PubMed
3031442Antimicrobial resistance of Staphylococcus aureus: genetic basis.Microbiol Rev1987https://conductscience.org/library/papers/3031442PubMed
814955Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli.Br Med J1976https://conductscience.org/library/papers/814955PubMed
321478Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.J Clin Pathol1977https://conductscience.org/library/papers/321478PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5115151

GET https://conductscience.org/api/papers/v1/5115151/authors